Skip to content

LONA LONA Operating Income

Operating Income at other companies

Arvinas logo
ArvinasARVN
-$63.8M-189%
Olema Pharmaceuticals, Inc. logo
Olema Pharmaceuticals, Inc.OLMA
-$57.99M-66.3%
Aura Biosciences, Inc. logo
Aura Biosciences, Inc.AURA
-$34.87M-20.1%
Inhibrx Biosciences, Inc. logo
Inhibrx Biosciences, Inc.INBX
-$30.93M+27.9%
Erasca, Inc. logo
Erasca, Inc.ERAS
-$187.91M-427%
Immunome logo
ImmunomeIMNM
-$59.33M-32.9%

Other financials

Income statement

See full
Net income-$32.9M-260%
EPS (diluted)-$1.73+26.1%

Balance sheet

See full
Cash & equivalents$32.8M+24.3%
Total debt$691.0K-38.2%
Total equity$49.3M+32.1%
Total assets$71.6M+64.5%

Cash flow

See full
Operating cash flow-$20.9M-42.5%
CapEx$28.0K-15.2%
Free cash flow-$26.0M+1.1%

Valuation

See full
Market cap$86.33M+235%
Enterprise value$54.18M

Returns & leverage

See full
Return on equity-298.8%-726pp
Debt / equity0.0×
Current ratio10.4×+3.1×

Where this comes from

Reported directly by LONA in its filing.

Tagged under the XBRL concept us-gaap:OperatingIncomeLoss.

The official record: LONA’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about LONA's operating income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is LONA's operating income?
LONA (LONA) reported operating income of -$17.21M in Q1 2026.
How has LONA's operating income changed year-over-year?
LONA's operating income decreased by 80.5% year-over-year, from -$9.54M to -$17.21M.
What is the long-term trend for LONA's operating income?
Over 4 years (2021 to 2025), LONA's operating income has grown at a 12.4% compound annual growth rate (CAGR), from -$64.02M to -$102.27M.
What does operating income mean?
Gross profit minus all operating expenses (SG&A, R&D, D&A). Measures the profit from core business operations before interest, taxes, and non-operating items.